Ipca Laboratories Ltd.
IPCALAB · ISIN: INE571A01038
Constituent of NIFTY 500 TRI (0.12%), NIFTY LMC 250 TRI (0.29%), NIFTY MC 150 TRI (0.58%)
Earnings (TTM)
CHART
Ipca Laboratories Ltd. - revenue & profit (TTM)
Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.
18.6%
EBITDA Margin (TTM)
51.63
EPS (TTM)
5.92%
EPS Growth (5Y)
26.92%
EPS Growth (10Y)
Technicals
64.68
RSI (14)
1831.55
SMA (50)
1586.93
SMA (200)
32.7
ADX (14)
2001.5
52-Week High
1251.6
52-Week Low
43.84%
1Y Return
134.2326
Avg Traded Value (20D, ₹Cr)
As of 2026-09-08.
Shareholding Pattern
CHART
Shareholding by category
As of 2026-06-30.
F&O Sentiment
Nearest expiry: 2025-02-27 · As of 2025-02-27.
0.752
PCR (OI)
0.6222
PCR (Volume)
1460
Max Pain Strike
Corporate Actions
| Ex-Date | Type | Ratio | Details |
|---|---|---|---|
| 2022-01-10 | SPLIT | 0.500000 | FACE VALUE SPLIT (SUB-DIVISION) - FROM RS 2/- PER SHARE TO RE 1/- PER SHARE |
Recent Deals
No recent block/bulk/short-sell deals on record for this stock.
Stock data · Not financial advice · Past performance does not indicate future returns